Double-blind, placebo-controlled, cross-over trial of probucol in heterozygous familial hypercholesterolaemia
- 1 May 1985
- journal article
- research article
- Published by Elsevier in Atherosclerosis
- Vol. 55 (2), 187-194
- https://doi.org/10.1016/0021-9150(85)90097-8
Abstract
No abstract availableThis publication has 22 references indexed in Scilit:
- Effect of probucol on the composition of lipoproteins and on VLDL apoprotein B turnoverAtherosclerosis, 1983
- The effects of probucol on plasma lipoproteins in polygenic and familial hypercholesterolaemiaAtherosclerosis, 1982
- High-Density Lipoprotein Cholesterol: Methods and Clinical SignificanceCRC Critical Reviews in Clinical Laboratory Sciences, 1982
- Effects of probucol on low density lipoprotein removal and high density lipoprotein synthesisAtherosclerosis, 1981
- High-density-lipoprotein cholesterol in the Maasai of East Africa: a cautionary note.BMJ, 1979
- Plasma apoprotein and lipoprotein lipid levels in vegetariansMetabolism, 1978
- H.D.L. CHOLESTEROL: THE VARIABLE COMPONENTSThe Lancet, 1978
- Mode of action of a new hypocholesteraemic drug (DH-581) in familial hypercholesteraemiaAtherosclerosis, 1972
- RISKS OF ISCHÆMIC HEART-DISEASE IN FAMILIAL HYPERLIPOPROTEINÆMIC STATESThe Lancet, 1969
- THE DISTRIBUTION AND CHEMICAL COMPOSITION OF ULTRACENTRIFUGALLY SEPARATED LIPOPROTEINS IN HUMAN SERUMJournal of Clinical Investigation, 1955